<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05042765</url>
  </required_header>
  <id_info>
    <org_study_id>#2021-61137</org_study_id>
    <nct_id>NCT05042765</nct_id>
  </id_info>
  <brief_title>Entheogen Resurgence</brief_title>
  <acronym>SERPNTS</acronym>
  <official_title>Entheogen Resurgence - Surveying Entheogen Retreat Participants in Naturalistic Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vireo Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vireo Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For the purpose of this anonymous, observational pilot survey, the investigators will define&#xD;
      &quot;entheogens&quot; as substances, generally derived from plants, that are ingested in order to&#xD;
      impact one's consciousness for therapeutic, religious, or spiritual purposes. This survey&#xD;
      will focus on the naturalistic use of entheogens and other substances including kambo,&#xD;
      ayahuasca, hapé, bufo, and sananga typically used in specific cultural and spiritual contexts&#xD;
      for healing. There are substantial limitations to what the healthcare community knows about&#xD;
      the intentions, motivations, experiences, health behaviors, and demographics of people who&#xD;
      decide to participate in entheogen therapy centers or retreats and their willingness to&#xD;
      participate in future research studies.&#xD;
&#xD;
      The primary goal of this observational pilot survey is to collect self-reported, anonymous&#xD;
      data from people who have opted to participate in entheogen therapy centers and retreats&#xD;
      during the last five (5) years on the topics of their initial intentions, motivations,&#xD;
      experiences, demographics, and willingness to participate in future entheogen research.&#xD;
&#xD;
      With the support of established therapy and retreat centers, the research team will aim to&#xD;
      collect 100 survey responses from unique, unidentified individuals who have participated in&#xD;
      some form of entheogen therapy or treatment during the last five (5) years. Those who choose&#xD;
      to fill out the survey will be at least 18 years of age, fluent in English, and&#xD;
      self-reporting participation in therapy or a retreat which utilized entheogens in a&#xD;
      naturalistic setting in the past five (5) years.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Entheogen Use in Naturalistic Retreat &amp; Therapeutic Settings</measure>
    <time_frame>Entheogen use will have occured within the last 5 years</time_frame>
    <description>The primary outcome will be self-reported experiences related to entheogen use in naturalistic retreat and therapeutic settings.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Psychedelic Experiences</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>self-reported entheogen use</intervention_name>
    <description>self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        People over the age of 18 years old who are fluent in English and have self-reported&#xD;
        participation in entheogen therapy centers or retreats in naturalistic settings during the&#xD;
        past five (5) years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;18 years old&#xD;
&#xD;
          -  Fluent in English&#xD;
&#xD;
          -  Self-reported participation in therapy or a retreat in a naturalistic setting that&#xD;
             incorporated the use of entheogens in the past five (5) years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
&#xD;
          -  Inability to complete the online questionnaire&#xD;
&#xD;
          -  No self-reported participation in therapy or a retreat in a naturalistic setting that&#xD;
             incorporated the use of entheogens in the past five (5) years&#xD;
&#xD;
          -  Self-reported participation in therapy or a retreat in naturalistic setting that&#xD;
             incorporated the use of entheogens greater than five (5) years ago&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Dahmer, ND</last_name>
    <role>Principal Investigator</role>
    <affiliation>Resurgent Biosciences, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivia M Uhley, BA</last_name>
    <phone>402-819-8955</phone>
    <email>oliviauhley@resurgentbiosciences.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephen Dahmer, MD</last_name>
    <phone>612-999-1606</phone>
    <email>stephendahmer@vireohealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vireo Health of New York</name>
      <address>
        <city>Queens</city>
        <state>New York</state>
        <zip>11373</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Dahmer, MD</last_name>
      <phone>612-999-1606</phone>
      <email>stephendahmer@vireohealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Olivia Uhley, BA</last_name>
      <phone>402-819-8955</phone>
      <email>oliviauhley@vireohealth.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>September 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Entheogen</keyword>
  <keyword>Psychedelic</keyword>
  <keyword>Hallucinogen</keyword>
  <keyword>Kambo</keyword>
  <keyword>Ayahuasca</keyword>
  <keyword>Hapé</keyword>
  <keyword>Bufo</keyword>
  <keyword>Sananga</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

